Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ACELYRIN, INC. Common Stock
SLRNCurrent price
5.16 USD
-0.94 USD (-15.41%)
Last closed
5.98 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
588 868 992 USD
Yield for 12 month
-43.61 %
1Y
3Y
5Y
10Y
15Y
SLRN
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease. In addition, the company's develops SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California. Address: 4149 Liberty Canyon Road, Agoura Hills, CA, United States, 91301
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.83 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-115 000 USD
Last Year
–
Current Quarter
-116 000 USD
Last Quarter
-55 000 USD
Key Figures SLRN
1 year
3 years
5 years
10 years
EBITDA
-423 561 984 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-35.63 %
PEG Ratio
–
Return On Equity TTM
-43.79 %
Wall Street Target Price
10.83 USD
Revenue TTM
–
Book Value
5.71 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.94 USD
Diluted Eps TTM
-1.94 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SLRN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SLRN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation SLRN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.456
Price Book MRQ
1.0363
Financials SLRN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SLRN
For 52 weeks
3.36 USD
9.25 USD
50 Day MA
5.31 USD
Shares Short Prior Month
6 390 118
200 Day MA
5.67 USD
Short Ratio
5.84
Shares Short
5 162 026
Short Percent
5.9 %
BeatStart